SLN logo

Silence Therapeutics (SLN) Depreciation And Amortization

Annual D&A

$619.70 K
+$22.80 K+3.82%

December 31, 2023

Summary

Performance

1-Year Change

+3.82%

3-Year Change

-2.65%

5-Year Change

+16.4%

15-Year Change

+10.84%

SLN Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.49%
SLN annual depreciation & amortization is higher than 31.49% of companies in Healthcare sector

High & Low

All-time High

$782.30 K
SLN annual depreciation & amortization is currently -20.78% below its historical high of $782.30 thousand

3-Year Low

$587.40 K
SLN annual depreciation & amortization is currently +5.50% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SLN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 13, 2025
SLN next annual earnings announcement is scheduled for Mar 13, 2025

Related metrics

Annual Total Expenses

$93.30 M
SLN annual total expenses is $93.30 million

Annual Operating Expenses

$80.46 M
SLN annual total operating expenses is $80.46 million

Annual Cost Of Goods Sold

$12.84 M
SLN annual cost of goods sold is $12.84 million

Annual Interest Expense

$42.30 K
SLN annual interest expense is $42.30 thousand

Quarterly D&A

$159.10 K
+$9800.00+6.56%

September 1, 2024

Summary

Performance

3-Month Change

+6.56%

1-Year Change

+11.81%

3-Year Change

-18.62%

5-Year Change

-18.62%

SLN Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

32.59%
SLN quarterly depreciation & amortization is higher than 32.59% of companies in Healthcare sector

High & Low

All-time High

$195.50 K
SLN quarterly depreciation & amortization is currently -18.62% below its historical high of $195.50 thousand

3-Year Low

$89.70 K
SLN quarterly depreciation & amortization is currently +77.37% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
SLN previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
SLN next earnings announcement is scheduled for Mar 13, 2025

Related metrics

Quarterly Total Expenses

$30.81 M
SLN quarterly total expenses is $30.81 million

Quarterly Operating Expenses

$27.20 M
SLN quarterly total operating expenses is $27.20 million

Quarterly Cost Of Goods Sold

$3.61 M
SLN quarterly cost of goods sold is $3.61 million

Quarterly Interest Expense

$11.19 M
SLN quarterly interest expense is $11.19 million

TTM D&A

$602.90 K
-$2900.00-0.48%

September 1, 2024

Summary

Performance

3-Month Change

-0.48%

1-Year Change

-2.71%

3-Year Change

+1.01%

5-Year Change

+1.01%

SLN TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

30.83%
SLN TTM depreciation & amortization is higher than 30.83% of companies in Healthcare sector

High & Low

All-time High

$672.90 K
SLN TTM depreciation & amortization is currently -10.40% below its historical high of $672.90 thousand

3-Year Low

$491.10 K
SLN TTM depreciation & amortization is currently +22.77% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
SLN previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
SLN next earnings announcement is scheduled for Mar 13, 2025

Related metrics

Annual Total Expenses

$93.30 M
SLN annual total expenses is $93.30 million

Annual Operating Expenses

$80.46 M
SLN annual total operating expenses is $80.46 million

TTM Cost Of Goods Sold

$11.42 M
SLN TTM cost of goods sold is $11.42 million

TTM Interest Expense

$11.36 M
SLN TTM interest expense is $11.36 million

SLN Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.8%+11.8%-2.7%
3 y3 years-2.6%-18.6%+1.0%
5 y5 years+16.4%-18.6%+1.0%

SLN Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+5.5%-18.6%+77.4%-10.4%+22.8%
5 y5-year-2.6%+5.5%-18.6%+77.4%-10.4%+241.8%
alltimeall time-20.8%>+9999.0%-18.6%+77.4%-10.4%+241.8%

Silence Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2024
-
$159.10 K(+6.6%)
$602.90 K(-0.5%)
Jun 2024
-
$149.30 K(-1.9%)
$605.80 K(-0.5%)
Mar 2024
-
$152.20 K(+7.0%)
$609.00 K(-1.7%)
Dec 2023
$619.70 K(+3.8%)
$142.30 K(-12.2%)
$619.70 K(-7.9%)
Sep 2023
-
$162.00 K(+6.2%)
$672.90 K(+7.3%)
Jun 2023
-
$152.50 K(-6.4%)
$626.90 K(+3.1%)
Mar 2023
-
$162.90 K(-16.7%)
$608.20 K(+1.9%)
Dec 2022
$596.90 K(+1.6%)
$195.50 K(+68.5%)
$596.90 K(+21.5%)
Sep 2022
-
$116.00 K(-13.3%)
$491.10 K(-5.9%)
Jun 2022
-
$133.80 K(-11.7%)
$522.00 K(-7.2%)
Mar 2022
-
$151.60 K(+69.0%)
$562.60 K(-4.2%)
Dec 2021
$587.40 K(-7.7%)
$89.70 K(-38.9%)
$587.40 K(+18.0%)
Sep 2021
-
$146.90 K(-15.8%)
$497.70 K(+41.9%)
Jun 2021
-
$174.40 K(-1.1%)
$350.80 K(+98.9%)
Mar 2021
-
$176.40 K
$176.40 K
Dec 2020
$636.60 K(+3.4%)
-
-
Dec 2019
$615.40 K(+15.6%)
-
-
Dec 2018
$532.40 K(-4.8%)
-
-
Dec 2017
$559.10 K(+33.1%)
-
-
Dec 2016
$420.00 K(+51.0%)
-
-
DateAnnualQuarterlyTTM
Dec 2015
$278.10 K(-49.2%)
-
-
Dec 2014
$547.30 K(+17.8%)
-
-
Dec 2013
$464.70 K(+16.4%)
-
-
Dec 2012
$399.30 K(-18.4%)
-
-
Dec 2011
$489.10 K(-1.8%)
-
-
Dec 2010
$497.90 K(-14.3%)
-
-
Dec 2009
$581.10 K(-25.7%)
-
-
Dec 2008
$782.30 K(+22.9%)
-
-
Dec 2007
$636.40 K(-2.2%)
-
-
Dec 2006
$650.80 K(+65.6%)
-
-
Dec 2005
$393.00 K(+464.7%)
-
-
Dec 2004
$69.60 K(-3.3%)
-
-
Dec 2003
$72.00 K(-14.5%)
-
-
Dec 2002
$84.20 K(+39.2%)
-
-
Dec 2001
$60.50 K(+37.5%)
-
-
Dec 2000
$44.00 K(+353.6%)
-
-
Dec 1999
$9700.00(-83.8%)
-
-
Dec 1998
$59.70 K(+7.2%)
-
-
Dec 1997
$55.70 K(+4.9%)
-
-
Dec 1996
$53.10 K(+3218.8%)
-
-
Dec 1995
$1600.00
-
-

FAQ

  • What is Silence Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Silence Therapeutics?
  • What is Silence Therapeutics annual D&A year-on-year change?
  • What is Silence Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Silence Therapeutics?
  • What is Silence Therapeutics quarterly D&A year-on-year change?
  • What is Silence Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Silence Therapeutics?
  • What is Silence Therapeutics TTM D&A year-on-year change?

What is Silence Therapeutics annual depreciation & amortization?

The current annual D&A of SLN is $619.70 K

What is the all time high annual D&A for Silence Therapeutics?

Silence Therapeutics all-time high annual depreciation & amortization is $782.30 K

What is Silence Therapeutics annual D&A year-on-year change?

Over the past year, SLN annual depreciation & amortization has changed by +$22.80 K (+3.82%)

What is Silence Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of SLN is $159.10 K

What is the all time high quarterly D&A for Silence Therapeutics?

Silence Therapeutics all-time high quarterly depreciation & amortization is $195.50 K

What is Silence Therapeutics quarterly D&A year-on-year change?

Over the past year, SLN quarterly depreciation & amortization has changed by +$16.80 K (+11.81%)

What is Silence Therapeutics TTM depreciation & amortization?

The current TTM D&A of SLN is $602.90 K

What is the all time high TTM D&A for Silence Therapeutics?

Silence Therapeutics all-time high TTM depreciation & amortization is $672.90 K

What is Silence Therapeutics TTM D&A year-on-year change?

Over the past year, SLN TTM depreciation & amortization has changed by -$16.80 K (-2.71%)